Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals
Year: 2019
Type: article
Authors: Saverio Candido, Stephen L. Abrams, Linda S. Steelman, Kvin Lertpiriyapong, Alberto M. Martelli, Lucio Cocco, Stefano Ratti, Matilde Y. Follo, Ramiro M. Murata, Pedro L. Rosalen, Bruno Bueno-Silva, Severino Matias de Alencar, Paolo Lombardi, Weifeng Mao, Giuseppe Montalto, Melchiorre Cervello, Dariusz Rakus, Agnieska Gizak, Heng-Liang Lin, Massimo Libra, Shaw M. Akula, James A. McCubrey
Institutions: University of Catania, East Carolina University, Hospital for Special Surgery, Weill Cornell Medicine, University of Bologna, Universidade Estadual de Campinas (UNICAMP), Guarulhos University, Universidade de São Paulo, Dalian Medical University, Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy, National Research Council, University of Palermo, University of Wrocław, Fu Jen Catholic University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: East Carolina University
Awards: G389751425, G464037143
OpenAlex ID: W2921099017